These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6986468

  • 1. Case report: progressive systemic sclerosis-like syndrome after bone marrow transplantation. Clinical, immunologic, and pathologic findings.
    Herzog P, Clements PJ, Roberts NK, Furst DE, Johnson CE, Feig SA.
    J Rheumatol; 1980; 7(1):56-64. PubMed ID: 6986468
    [Abstract] [Full Text] [Related]

  • 2. Scleroderma-like changes in chronic graft vs host disease.
    Spielvogel RL, Goltz RW, Kersey JH.
    Arch Dermatol; 1977 Oct; 113(10):1424-8. PubMed ID: 20854
    [Abstract] [Full Text] [Related]

  • 3. A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma?
    Furst DE, Clements PJ, Graze P, Gale R, Roberts N.
    Arthritis Rheum; 1979 Aug; 22(8):904-10. PubMed ID: 37843
    [Abstract] [Full Text] [Related]

  • 4. Acute graft-versus-host disease of the heart.
    Roberts SS, Leeborg N, Loriaux M, Johnson FL, Huang ML, Stenzel P, Thiede C, Godder KT.
    Pediatr Blood Cancer; 2006 Oct 15; 47(5):624-8. PubMed ID: 16206193
    [Abstract] [Full Text] [Related]

  • 5. [Chronic graft-versus-host reaction following bone marrow transplantation].
    Ippen H, Nagel G.
    Hautarzt; 1984 Apr 15; 35(4):182-7. PubMed ID: 6373672
    [Abstract] [Full Text] [Related]

  • 6. Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease.
    Wolff D, Reichenberger F, Steiner B, Kahl C, Leithäuser M, Skibbe T, Friedrich T, Terpe H, Helbig W, Freund M.
    Bone Marrow Transplant; 2002 Feb 15; 29(4):357-60. PubMed ID: 11896434
    [Abstract] [Full Text] [Related]

  • 7. Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models.
    Bos GM, Majoor GD, Slaaf DW, van de Gaar MJ, Weijmer-van Velzen JS, van Breda Vriesman PJ.
    Transplant Proc; 1989 Apr 15; 21(2):3262-3. PubMed ID: 2652812
    [No Abstract] [Full Text] [Related]

  • 8. Bullous sclerodermalike changes in chronic graft-vs-host disease.
    Hymes SR, Farmer ER, Burns WH, Morison WL, Tutschka PJ, Walters LL, Santos GW.
    Arch Dermatol; 1985 Sep 15; 121(9):1189-92. PubMed ID: 3899019
    [Abstract] [Full Text] [Related]

  • 9. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Urban CH, Deutschmann A, Kerbl R, Lackner H, Schwinger W, Königsrainer A, Margreiter R.
    Bone Marrow Transplant; 2002 Oct 15; 30(8):535-7. PubMed ID: 12379895
    [Abstract] [Full Text] [Related]

  • 10. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E, Ołdakowska-Jedynak U, Brydak-Godowska J, Paczek L, Kecik D.
    Transplant Proc; 2006 Oct 15; 38(1):292-4. PubMed ID: 16504728
    [Abstract] [Full Text] [Related]

  • 11. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
    Skert C, Patriarca F, Sperotto A, Cerno M, Filì C, Zaja F, Stocchi R, Geromin A, Damiani D, Fanin R.
    Haematologica; 2006 Feb 15; 91(2):258-61. PubMed ID: 16461315
    [Abstract] [Full Text] [Related]

  • 12. In vivo demonstration of microvascular pathology by intravital microscopy in experimental chronic graft-versus-host disease: analogy with scleroderma.
    Bos G, Majoor G, Slaaf D, Reneman R, van Breda Vriesman P.
    J Rheumatol; 1988 Sep 15; 15(9):1339-45. PubMed ID: 3058970
    [Abstract] [Full Text] [Related]

  • 13. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ.
    J Clin Invest; 1998 May 01; 101(9):1835-42. PubMed ID: 9576746
    [Abstract] [Full Text] [Related]

  • 14. [Pulmonary disease as the chief manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Ohtaka M, Suzuki A, Gotoh A, Nagasu M, Torii Y, Kimura Y, Ichinose Y, Toyama K, Serizawa H, Ebihara Y.
    Rinsho Ketsueki; 1993 Feb 01; 34(2):153-8. PubMed ID: 8492413
    [Abstract] [Full Text] [Related]

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 01; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan 01; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.
    Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE.
    Bone Marrow Transplant; 1994 Nov 01; 14(5):845-8. PubMed ID: 7889018
    [Abstract] [Full Text] [Related]

  • 18. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation.
    Yabe M, Yabe H, Hattori K, Morimoto T, Hinohara T, Takakura I, Shimizu T, Shimamura K, Tang X, Kato S.
    Bone Marrow Transplant; 1997 Feb 01; 19(4):389-92. PubMed ID: 9051251
    [Abstract] [Full Text] [Related]

  • 19. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K, Hashino S, Shimizu K, Yonezumi M, Chiba K, Kondo T, Suzuki S, Imamura M, Asaka M.
    Rinsho Ketsueki; 2004 Sep 01; 45(9):1044-7. PubMed ID: 15510833
    [Abstract] [Full Text] [Related]

  • 20. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C, Benyunes MC, Sale G, Beauchamp M, York A, Thompson JA, Buckner CD, Fefer A.
    Bone Marrow Transplant; 1996 Mar 01; 17(3):351-6. PubMed ID: 8704686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.